Table 1
Deaths and YLLs From the 30 Leading Diseases and Injuries Contributing to YLLs in the United States in 1990 and 2010 and Percentage Change From 1990 to 2010 in YLLs and Age-Standardized YLL Ratesa
Diseases and Injuries YLL Rank Deaths YLLs 1990 2010 No. (in Thousands) Median Change, % No. (in Thousands) Median Change, % 1990 2010 Deaths Age-Standardized Death Rate 1990 2010 YLLs Age-Standardized YLL Rate Ischemic heart disease 1 (1-1) 1 (1-1) 648.2 (600.8-676.1) 562.9 (515.4-662.1) −14.4 (−20.6 to 2.6) −43.6 (−47.1 to −33.2) 8990.3 (8386.2-9451.4) 7164.5 (6706.6-8198.2) −21.2 (−25.6 to −9.1) −45.2 (−48.2 to −38.1) Lung cancer 2 (2-3) 2 (2-2) 143.5 (116.8-178.5) 163.3 (128.1-200.8) 14.4 (−1.1 to 26.0) −22.5 (−31.8 to −14.7) 2871.9 (2325.8-3523.2) 2987.7 (2418.1-3731.2) 3.6 (−6.6 to 17.4) −30 (−36.1 to −18.9) Stroke 4 (3-4) 3 (3-5) 177.8 (163.7-200.9) 172.3 (153.5-201.7) −3 (−13.6 to 8.2) −36.7 (−43.0 to −30.4) 2250.4 (2096.3-2543.6) 1945.3 (1741.8-2147.8) −13.2 (−21.5 to −6.2) −39.3 (−45.6 to −34.8) Chronic obstructive pulmonary disease 5 (5-8) 4 (3-5) 97.5 (90.3-105.5) 154.5 (137.8-170.0) 58.3 (43.3 to 75.7) 5.6 (−3.0 to 16.3) 1416.1 (1308.5-1534.0) 1913.1 (1720.9-2067.9) 34.7 (24.7 to 47.1) −5.8 (−12.5 to 2.7) Road injury 3 (2-4) 5 (3-6) 49.6 (43.4-59.2) 44.0 (36.2-53.5) −11.7 (−21.8 to 3.4) −30.2 (−37.5 to −17.7) 2336.5 (2022.5-2752.3) 1873.2 (1569.0-2280.1) −20.4 (−28.4 to −4.3) −33.3 (−39.7 to −19.4) Self-harm 6 (5-10) 6 (5-10) 33.7 (25.6-43.7) 37.3 (27.6-47.1) 10.8 (−6.2 to 26.7) −12.9 (−27.2 to −1.6) 1393.8 (1068.6-1808.7) 1456.9 (1066.1-1779.0) 5.7 (−13.2 to 18.1) −13.2 (−28.3 to − −2.4) Diabetes 15 (11-15) 7 (6-9) 50.2 (45.3-60.0) 86.1 (73.0-99.3) 71.8 (43.7 to 97.1) 17.3 (−1.3 to 32.4) 875.0 (788.0-1042.3) 1392.4 (1186.7-1568.1) 60.1 (34.5 to 78.3) 13.0 (−5.4 to 25.7) Cirrhosis 14 (10-15) 8 (7-12) 35.5 (31.3-42.1) 49.5 (39.5-54.6) 43.3 (14.0 to 56.0) −2 (−22.5 to 6.4) 917.3 (808.7-1095.1) 1232.7 (966.2-1364.7) 37.9 (9.8 to 50.8) −5.3 (−23.8 to 3.3) Alzheimer disease 32 (23-38) 9 (6-20) 27.0 (19.8-45.7) 158.3 (75.8-237.4) 524.3 (136.8 to 877.4) 289.6 (56.5 to 487.6) 257.4 (202.1-407.1) 1192.4 (637.0-1648.1) 391.6 (128.5 to 593.1) 209.5 (60.4 to 315.7) Colorectal cancer 11 (9-14) 10 (7-13) 60.2 (49.6-67.1) 63.9 (55.4-88.1) 1.6 (−9.4 to 49.7) −29.4 (−36.1 to 2.4) 1018.9 (855.4-1127.3) 1073.6 (946.9-1412.7) 1.6 (−7.6 to 41.8) −27.5 (−33.9 to −0.8) Lower respiratory tract infections 10 (7-11) 11 (8-13) 90.4 (71.9-103.3) 85.4 (69.4-114.0) −8.1 (−27.8 to 34.7) −38.6 (−49.7 to −14.1) 1185.7 (996.4-1303.8) 1031.8 (905.9-1261.3) −14.3 (−26.1 to 8.4) −37.6 (−44.9 to −26.1) Interpersonal violence 8 (5-13) 12 (7-16) 25.2 (17.7-30.9) 19.9 (15.9-28.3) −24.4 (−33.8 to 8.2) −34.4 (−42.7 to −7.9) 1344.3 (948.9-1660.1) 1019.1 (795.8-1427.6) −26.5 (−36.0 to 2.9) −33.9 (−42.8 to −8.9) Breast cancer 12 (11-14) 13 (12-16) 43.2 (40.4-47.0) 42.6 (37.4-47.5) −1.2 (−12.6 to 10.0) −33.4 (−40.0 to −26.6) 953.7 (890.0-1020.1) 891.7 (804.6-980.7) −6.5 (−14.3 to 2.4) −35.9 (−41.0 to −29.8) Preterm birth complications 9 (6-12) 14 (11-18) 14.1 (11.3-16.8) 10.0 (8.0-12.3) −29.6 (−45.9 to −5.1) −35.7 (−50.5 to −13.3) 1213.2 (970.1-1440.7) 858.4 (687.4-1061.3) −29.6 (−45.9 to −5.1) −35.7 (−50.5 to −13.3) Drug use disorders 44 (24-49) 15 (8-28) 3.8 (2.6-8.5) 19.4 (9.3-28.6) 477.4 (105.1 to 699.8) 376.6 (69.3 to 559.6) 174.1 (118.4-399.1) 840.6 (387.6-1239.2) 448.4 (88.0 to 673.8) 376.6 (65.3 to 565.7) Chronic kidney disease 21 (19-25) 16 (13-20) 30.4 (26.0-37.5) 60.3 (47.4-74.0) 99 (58.8 to 141.4) 33.9 (7.8 to 59.2) 425.2 (374.2-521.6) 780.2 (636.7-908.4) 85.8 (47.4 to 112.2) 32.4 (4.2 to 49.9) Other cardiovascular/circulatory 16 (16-18) 17 (15-19) 40.9 (38.6-43.3) 56.6 (50.5-63.7) 38.2 (21.8 to 57.2) −8.7 (−17.8 to 1.0) 636.1 (611.3-662.0) 765.4 (709.1-824.0) 20.3 (10.2 to 30.2) −14.4 (−21.1 to −7.6) Pancreatic cancer 19 (16-23) 18 (13-23) 28.6 (21.7-39.1) 39.0 (28.7-52.8) 37 (15.5 to 58.7) −4.9 (−19.0 to 8.4) 508.6 (391.5-669.5) 679.9 (500.1-908.3) 34.3 (15.2 to 51.4) −6.3 (−19.8 to 5.6) Congenital anomalies 13 (11-15) 19 (15-22) 13.4 (11.2-15.8) 12.4 (10.8-15.1) −8.3 (−18.1 to 8.2) −32.3 (−39.0 to −14.7) 937.1 (762.0-1086.5) 660.8 (579.6-842.1) −31.3 (−39.0 to −6.8) −41.1 (−48.1 to −18.3) Cardiomyopathy 18 (16-19) 20 (13-22) 30.7 (26.2-32.7) 36 (30.9-46.7) 15.4 (−1.0 to 71.3) −22.9 (−32.6 to 18.0) 622.7 (533.7-659.8) 659.4 (571.7-908.0) 3.3 (−9.8 to 63.1) −24.2 (−34.1 to 18.2) Hypertensive heart disease 17 (16-19) 21 (16-23) 41.4 (33.2-51.4) 44.7 (34.8-59.6) 7.4 (−10.5 to 30.6) −29.1 (−39.2 to −15.7) 625.8 (522.0-768.2) 641.9 (531.5-800.8) 2.2 (−10.3 to 18.1) −28.1 (−37.2 to −18.7) Leukemia 20 (19-24) 22 (21-29) 20.3 (16.4-25.3) 25.5 (20.0-31.6) 25.9 (3.3 to 45.1) −13 (−25.2 to −2.7) 458.3 (373.9-562.8) 493.6 (402.2-611.1) 7.8 (−3.7 to 19.3) −20.5 (−28.9 to −11.1) Human immunodeficiency virus/AIDS 7 (5-9) 23 (22-27) 28.6 (25.6-31.9) 12.1 (10.6-13.7) −57.7 (−63.5 to −50.5) −67.7 (−72.1 to −62.3) 1351.1 (1201.1-1508.5) 479.2 (417.4-542.2) −64.5 (−69.6 to −58.1) −71.6 (−75.8 to −66.5) Kidney cancers 35 (28-45) 24 (16-31) 10.7 (7.5-14.2) 24.4 (17.1-39.8) 114.9 (60.0 to 262.5) 47 (9.7 to 146.3) 216.9 (152.7-282.0) 475.7 (334.5-796.4) 104.7 (53.1 to 247.1) 40.9 (5.7 to 144.0) Non-Hodgkin lymphoma 22 (20-26) 25 (22-30) 20 (16.8-23.5) 25.2 (20.3-30.2) 25.4 (2.4 to 52.4) −14.6 (−28.0 to 3.5) 407.8 (339.9-465.4) 451.6 (375.7-541.7) 8.6 (−5.7 to 38.5) −23.6 (−33.4 to −0.2) Poisonings 31 (22-38) 26 (18-45) 5.9 (4.5-9.6) 11.4 (4.2-16.2) 117.1 (−34.4 to 229.4) 76.1 (−46.7 to 173.3) 263.6 (201.7-433.8) 485.7 (172.9-693.0) 108.1 (−39.3 to 220.0) 74.3 (−48.1 to 173.5) Prostate cancer 23 (18-35) 27 (16-35) 30.8 (16.6-44.3) 35.9 (20.8-65.4) 9.7 (−30.0 to 89.7) −25.2 (−49.5 to 26.6) 417.9 (223.7-599.7) 445.6 (250.9-787.1) −1.6 (−30.1 to 62.4) −29.6 (−48.8 to 15.5) Brain cancer 24 (19-31) 28 (21-34) 14 (9.8-21.1) 16.5 (10.9-24.4) 18 (−8.1 to 45.3) −18 (−33.4 to −3.4) 383.3 (262.8-551.6) 411.2 (279.8-611.0) 7.1 (−9.9 to 26.9) −22 (−33.8 to −7.5) Falls 33 (26-36) 29 (24-35) 14.5 (12.1-19.7) 31.6 (18.7-41.7) 136.4 (11.3 to 220.9) 52 (−25.4 to 96.0) 245.4 (215.5-321.9) 400.2 (265.4-489.2) 79.3 (−3.6 to 117.3) 20.9 (−30.3 to 42.9) Liver cancer 39 (33-43) 30 (25-35) 9.3 (8.3-11.9) 19.5 (13.3-22.7) 118.4 (36.1 to 151.3) 55.3 (−4.9 to 76.4) 184.7 (167.7-235.4) 398.9 (260.6-461.5) 125.5 (34.9 to 156.5) 58.5 (−6.4 to 80.5) aDiseases and injuries contributing to years of life lost due to premature mortality (YLLs) are ranked by the magnitude of YLLs in 2010. 95% uncertainty intervals are shown in parentheses for all data.